The combined use of fibrinolytic and anticoagulant agents. Laboratory and clinical considerations.
D000925:Anticoagulants / Q000628:therapy*; D003850:Deoxyribonuclease I; D005341:Fibrinolysin / Q000628:therapy*; D006801:Humans; D013299:Streptodornase and Streptokinase / Q000628:therapy*; D013300:Streptokinase; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000628:therapy*
D000925:Anticoagulants; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase; D005341:Fibrinolysin
ANTICOAGULANTS/therapy; FIBRINOLYSIN/therapy; STREPTODORNASE AND STREPTOKINASE/therapy; THROMBOSIS/therapy